Newcastle University-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2022

  1. Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

    European Neuropsychopharmacology, Vol. 54, pp. 90-99

2021

  1. Corrigendum to “Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]” (European Neuropsychopharmacology (2020) 36 (121–136), (S0924977X20301802), (10.1016/j.euroneuro.2020.05.006))

    European Neuropsychopharmacology

2014

  1. Staging systems in bipolar disorder: An International Society for Bipolar Disorders Task Force Report

    Acta Psychiatrica Scandinavica, Vol. 130, Núm. 5, pp. 354-363

2013

  1. The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    American Journal of Psychiatry, Vol. 170, Núm. 11, pp. 1249-1262

2009

  1. Anticonvulsants in the treatment of aggression in the demented elderly: An update

    Clinical Practice and Epidemiology in Mental Health, Vol. 5

  2. Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use

    Journal of Clinical Psychiatry, Vol. 70, Núm. 8, pp. 1120-1127

2008

  1. Attitudes of patients and family members towards implantable psychiatric medication

    Schizophrenia Research, Vol. 105, Núm. 1-3, pp. 279-286